Department of Clinical Immunology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India.
Department of Biostatistics, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India.
Rheumatology (Oxford). 2023 Dec 1;62(12):3899-3908. doi: 10.1093/rheumatology/kead148.
SLE is associated with significant mortality, and data from South Asia is limited. Thus, we analysed the causes and predictors of mortality and hierarchical cluster-based survival in the Indian SLE Inception cohort for Research (INSPIRE).
Data for patients with SLE was extracted from the INSPIRE database. Univariate analyses of associations between mortality and a number of disease variables were conducted. Agglomerative unsupervised hierarchical cluster analysis was undertaken using 25 variables defining the SLE phenotype. Survival rates across clusters were assessed using non-adjusted and adjusted Cox proportional-hazards models.
Among 2072 patients (with a median follow-up of 18 months), there were 170 deaths (49.2 deaths per 1000 patient-years) of which cause could be determined in 155 patients. 47.1% occurred in the first 6 months. Most of the mortality (n = 87) were due to SLE disease activity followed by coexisting disease activity and infection (n = 24), infections (n = 23), and 21 to other causes. Among the deaths in which infection played a role, 24 had pneumonia. Clustering identified four clusters, and the mean survival estimates were 39.26, 39.78, 37.69 and 35.86 months in clusters 1, 2, 3 and 4, respectively (P < 0.001). The adjusted hazard ratios (HRs) (95% CI) were significant for cluster 4 [2.19 (1.44, 3.31)], low socio-economic-status [1.69 (1.22, 2.35)], number of BILAG-A [1.5 (1.29, 1.73)] and BILAG-B [1.15 (1.01, 1.3)], and need for haemodialysis [4.63 (1.87,11.48)].
SLE in India has high early mortality, and the majority of deaths occur outside the health-care setting. Clustering using the clinically relevant variables at baseline may help identify individuals at high risk of mortality in SLE, even after adjusting for high disease activity.
系统性红斑狼疮(SLE)与较高的死亡率相关,而南亚地区的数据有限。因此,我们分析了印度 SLE 发病队列研究(INSPIRE)中 SLE 患者的死亡原因和预测因素,并进行基于层次聚类的生存分析。
从 INSPIRE 数据库中提取 SLE 患者的数据。对死亡率与多种疾病变量之间的关联进行单因素分析。使用 25 个定义 SLE 表型的变量进行无监督聚集层次聚类分析。使用非调整和调整后的 Cox 比例风险模型评估各聚类的生存率。
在 2072 例患者中(中位随访 18 个月),有 170 例死亡(每 1000 例患者年死亡 49.2 例),其中 155 例死亡原因可确定。47.1%的死亡发生在发病后的前 6 个月。大多数死亡(n=87)归因于 SLE 疾病活动,其次是并存的疾病活动和感染(n=24)、感染(n=23)和其他原因(n=21)。在感染起作用的死亡中,有 24 例为肺炎。聚类分析确定了 4 个聚类,聚类 1、2、3 和 4 的平均生存估计分别为 39.26、39.78、37.69 和 35.86 个月(P<0.001)。调整后的风险比(HR)(95%CI)在聚类 4(2.19[1.44,3.31])、低社会经济地位(1.69[1.22,2.35])、BILAG-A 评分(1.5[1.29,1.73])和 BILAG-B 评分(1.15[1.01,1.3])以及需要血液透析(4.63[1.87,11.48])方面有显著意义。
印度的 SLE 死亡率较高,且大部分死亡发生在医疗保健环境之外。使用基线时具有临床意义的变量进行聚类分析可能有助于识别 SLE 患者的高死亡风险个体,即使在调整了疾病活动度较高的因素后也是如此。